eye problems with semaglutide Damage Specialists discuss concerns over impact

Any questions I had were answered right away

The future of metabolic management isn't just about less frequent dosing, its about ensuring a comprehensive, high-quality patient experience throughout the entire journey

Another reminder that metabolic and neurobehavioral regulation are deeply interconnected

A 6-week phase 1 study of participants without T2D who had overweight or obesity found reduced activation (estimated from blood oxygen level dependent signal functional MRI) in certain brain regions relevant to appetite regulation in response to high-fat/high-sugar food images among participants assigned to tirzepatide 10 mg as compared with placebo [75]

Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink)